rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2006-3-13
|
pubmed:abstractText |
To evaluate whether preoperative hyperfractionated accelerated radiotherapy (RT) combined with major radical surgery is feasible and successful in the treatment of advanced primary head and neck cancer.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0167-8140
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
78
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
146-51
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16307813-Adult,
pubmed-meshheading:16307813-Aged,
pubmed-meshheading:16307813-Aged, 80 and over,
pubmed-meshheading:16307813-Carcinoma, Squamous Cell,
pubmed-meshheading:16307813-Cause of Death,
pubmed-meshheading:16307813-Disease-Free Survival,
pubmed-meshheading:16307813-Dose Fractionation,
pubmed-meshheading:16307813-Feasibility Studies,
pubmed-meshheading:16307813-Female,
pubmed-meshheading:16307813-Follow-Up Studies,
pubmed-meshheading:16307813-Glottis,
pubmed-meshheading:16307813-Head and Neck Neoplasms,
pubmed-meshheading:16307813-Humans,
pubmed-meshheading:16307813-Laryngeal Neoplasms,
pubmed-meshheading:16307813-Lymphatic Metastasis,
pubmed-meshheading:16307813-Male,
pubmed-meshheading:16307813-Middle Aged,
pubmed-meshheading:16307813-Mouth Neoplasms,
pubmed-meshheading:16307813-Neck Dissection,
pubmed-meshheading:16307813-Neoplasm Recurrence, Local,
pubmed-meshheading:16307813-Neoplasm Staging,
pubmed-meshheading:16307813-Oropharyngeal Neoplasms,
pubmed-meshheading:16307813-Preoperative Care,
pubmed-meshheading:16307813-Prospective Studies,
pubmed-meshheading:16307813-Radiotherapy, Adjuvant,
pubmed-meshheading:16307813-Survival Rate,
pubmed-meshheading:16307813-Treatment Outcome
|
pubmed:year |
2006
|
pubmed:articleTitle |
Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
|
pubmed:affiliation |
Department of Oncology and Radiotherapy, University of Turku, Turku, Finland. paula.lindholm@tyks.fi
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase II
|